KRISTIAN STEEN FREDERIKSEN – PHYSICAL EXERCISE AND CLINICAL APPLICATION OF AD BIOMARKERS
MD, PhD. Main research areas are physical exercise in neurodegenerative dementias with regard to treatment and primary prevention. A second area of interest is the application of biomarkers of AD and other neurodegenerative diseases in the clinic, with a special focus on brain imaging techniques.
CHRISTINA JENSEN-DAHM – EPIDEMIOLOGY AND REGISTER-BASED RESEARCH
MD, PhD. Major research focus is epidemiological studies based on registry data. Current research focuses on medication use (analgesics, anti-dementia drugs, psychotropic medication and polypharmacy) in elderly with dementia, diagnosis of dementia and ethnicity.
IDA UNMACK LARSEN – COGNITION AND PERSONALITY IN HUNTINGTONS DISEASE
Neuropsychologist, PhD. This PhD project investigates neuropsychological impairments in executive functions and social cognition in the premanifest and early manifest stages of HD. Also conducted were exploratory studies investigating whether carrying the HD gene or growing up in an HD family will affect personality traits.
MALENE SCHJØNNING NIELSEN – MILD COGNITIVE IMPAIRMENT
MD. Her PhD project examines the diagnostic and prognostic value of three simple, inexpensive and widely available methods in the assessment of patients with MCI and AD.
LISE CRONBERG SALEM – DEMENTIA IN PEOPLE WITH DOWN SYNDROME MD, PhD.
Main research focus is studying diagnostic tools (e.g. quantitative EEG) to improve the diagnostic evaluation of dementia in patients with intellectual disabilities, which may be a difficult task due to their impaired ability to cooperate with regard to common diagnostic methods, such as lumbalpuncture and advanced scans of the brain.
TUA VINTER-JENSEN – CLINICAL SYMPTOMS IN HUNTINGTON’S DISEASE AND POSSIBLE BIOMARKERS PREDICTING DISEASE COURSE
MD, PhD. Studied a cohort of manifest and premanifest HD gene-expansion carriers with neurological, psychiatric and cognitive examination, together with blood and CSF analysis and MR/PET-FDG and will offer follow-up to identify biomarker predictors.